2 October 2019
This announcement contains inside information
Wilmcote Holdings plc
Statement regarding potential acquisition
Wilmcote Holdings Plc ("Wilmcote" or the "Company") announces that further to the statements made on 4 June 2019 and 18 July 2019, it has evaluated a range of transaction structures regarding the potential acquisition of US-based speciality chemicals business, Arclin Inc ("Arclin"). The Company will not be pursuing a direct acquisition for Arclin by Wilmcote, however the Company remains interested in indirectly participating in a possible acquisition of Arclin by an unaffiliated US-listed investment vehicle. It is anticipated a successful transaction will result in the Wilmcote management group being engaged by the unaffiliated US-listed investment vehicle and is expected to include provision for Wilmcote to receive compensation to reflect its investment in the acquisition opportunity.
Whilst there can be no certainty of a successful transaction, the Board believe that this approach is the most likely way of creating shareholder value through a successful acquisition of Arclin by an unaffiliated US-listed investment vehicle.
Given the continued uncertainty over the transaction structure and financial impact to Wilmcote and its shareholders, Wilmcote's ordinary shares remain suspended pending a further announcement in relation to this transaction.
Teneo (Financial PR)
Tel: +44 (0) 7703 330 269
Charles Armitstead
Numis Securities Limited (Nominated Adviser and Broker)
Tel: +44 (0) 20 7260 1000
Kevin Cruickshank
Jamie Loughborough
Adrian Whitfield is Chief Executive Officer of Wilmcote Holdings plc, which has its offices at 11 Buckingham Street, London, WC2N 6DF and has the LEI number 2138004EUUU11OVHZW75.